In the United States, 1.5 million people abuse cocaine leading to a host of negative health and economic consequences, yet no FDA approved treatment exists. To develop effective treatments, the following must be considered: 1) do potential medications ameliorate brain disruptions associated with cocaine use? 2) are multiple, targeted treatments necessary? To meet these goals, innovative multi-modal neuroimaging will be used to determine whether rebalancing the serotonergic (5-HT) system reduces cocaine cue reactivity, impulsivity, and normalizes related neurochemistry and brain connectivity.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
10 mg acute administration of lorcasein
Placebo
McLean Hospital
Belmont, Massachusetts, United States
Influence of lorcaserin on fMRI measured brain-reactivity to drug cues.
Time frame: fMRI measures will be gathered on scanning visits 1 and 2 (approx 1 week apart)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.